U.S. Oil and Gas Stock News

As February 2026 begins, U.S. stock markets have shown strong momentum with major indexes like the Dow and S&P 500 ending sharply higher, reflecting investor optimism amid recent economic developments such as trade deals and manufacturing growth. In this buoyant market environment, companies with high insider ownership often attract attention as their leadership's vested interest can signal confidence in long-term growth potential.

As February begins, major U.S. stock indexes have shown a strong start, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. In this context of market optimism, investors may find interest in exploring penny stocks—an investment area that often involves smaller or newer companies. Although the term "penny stocks" might seem outdated, these investments can still offer surprising value and potential for growth when backed by solid financial health.

As February 2026 begins, the U.S. stock market is experiencing a strong start with major indices like the Dow Jones and S&P 500 showing significant gains, reflecting a positive investor sentiment despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this vibrant yet complex environment, identifying promising small-cap stocks requires careful consideration of factors like market resilience and growth potential amidst evolving economic conditions.

As February 2026 begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. In this dynamic market environment, dividend stocks can offer investors a blend of income and potential growth, making them an attractive consideration amidst ongoing economic developments.

In February 2026, Humacyte, Inc. reported that the U.S. Department of Defense’s Fiscal Year 2026 Appropriations Act includes dedicated funding to evaluate and incorporate biologic vascular repair technologies, directly aligning with its FDA-approved human-derived bioengineered blood vessel Symvess for traumatic extremity vascular injuries in service members. This federal support highlights growing institutional recognition of bioengineered human vessels as an off-the-shelf option when...

Evommune (EVMN) is back in focus after reporting statistically significant positive top-line results from its Phase 2a EVO301 trial in moderate to severe atopic dermatitis, including clear separation from placebo and a favorable safety readout. See our latest analysis for Evommune. The positive EVO301 data has coincided with a sharp re-rating in the stock, with a 1-day share price return of 70.87% and a year-to-date share price return of 67.71% off a last close of $29.03. This indicates...

Southside Bancshares (SBSI) shares are trading around $33.30 after the bank reported full year 2025 results, which showed higher net interest income but lower net income and earnings per share compared with 2024. See our latest analysis for Southside Bancshares. The stock’s recent performance reflects mixed sentiment, with a 15.54% 90 day share price return and 9.36% year to date share price return. The 3 year total shareholder return is slightly negative and the 5 year total shareholder...

CNA Financial (CNA) has wrapped up FY 2025 with fourth quarter total revenue of US$3.8 billion, basic EPS of US$1.11 and net income of US$302 million. Its trailing twelve month figures show revenue of US$15.0 billion, EPS of US$4.71 and net income of US$1.28 billion. Over the past year, the company has seen revenue move from US$14.3 billion to US$15.0 billion and trailing EPS shift from US$3.53 to US$4.71. This sets the backdrop for how you might read this latest print. With net profit margin...

If you are wondering whether JFrog shares at about US$53.20 still offer value, you are not alone. This article breaks down what that price might really represent. The stock has been volatile, with a 2.7% return over the last 7 days, a 10.2% decline over 30 days, a 10.7% decline year to date, and a 48.0% return over 1 year, alongside a 119.8% return over 3 years and a 23.2% decline over 5 years. Recent coverage of JFrog has focused on its role in software development tooling and how investors...

Alvotech (ALVO) shares have been in focus after the company reported positive top line pharmacokinetic data for its AVT80 biosimilar candidate to Entyvio, along with new supply and commercialization agreements with Sandoz in Canada, Australia and New Zealand. See our latest analysis for Alvotech. These fresh clinical results and the Sandoz agreements come after a mixed share price pattern, with a 12.07% 1 month share price return and a 4.00% year to date share price return contrasting with a...

Setting the scene with Danaos's latest numbers Danaos (DAC) has just wrapped up FY 2025 with fourth quarter revenue of US$266.3 million and basic EPS of US$6.43, capping a year in which trailing twelve month revenue sat at about US$1.0 billion and EPS at US$26.83. The company has seen revenue move from US$258.2 million and EPS of US$4.72 in Q4 2024 to the latest Q4 2025 figures. Over the same period, trailing twelve month revenue slipped from US$1.01 billion and EPS from US$26.15 a year...

In late January 2026, CONMED Corporation reported fourth-quarter 2025 sales of US$373.2 million and full-year sales of US$1.37 billion, alongside a sharp year-on-year fall in net income to US$16.74 million for the quarter and US$47.06 million for the year. While revenue increased, the sizeable drop in earnings per share from continuing operations to US$0.54 for the quarter and US$1.51 for the year, combined with 2026 revenue guidance of US$1.345–1.375 billion, highlights a tension between...

Hawkins' subsidiary WaterSurplus will supply 1,050 NanoStack coated membranes to the Orange County Water District’s Groundwater Replenishment System. The decision follows a successful pilot and represents deployment into what is described as the world’s leading potable water reuse system. The project highlights Hawkins' role in advanced water treatment solutions for large scale reuse facilities. For investors watching NasdaqGS:HWKN, this contract sits alongside a share price of $143.51 and...

The Gorman-Rupp Company ( NYSE:GRC ) shares have continued their recent momentum with a 31% gain in the last month...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

How Bank of N.T. Butterfield & Son (NYSE:NTB)'s FY 2025 Numbers Set the Stage Bank of N.T. Butterfield & Son (NYSE:NTB) has reported a clean set of FY 2025 numbers, with fourth quarter revenue of US$159.1 million and basic EPS of US$1.58 anchoring the latest release. Over the past year, the bank has recorded trailing twelve month revenue of US$606.7 million and basic EPS of US$5.71. This gives investors a fuller picture of how the quarterly performance fits within the broader trend. With a...

What recent returns suggest about Cognex (CGNX) Cognex (CGNX) has delivered a 0.1% move over the past day, with gains of 6.7% over the past week and around 12% over the past month, leaving the shares near US$43.58. Over the past 3 months the stock shows a total return of about 14%, while the 1 year total return is roughly 11%. Longer term, 3 year and 5 year total returns sit in negative territory. See our latest analysis for Cognex. For Cognex, the recent 7 day and 30 day share price returns...

SiteOne Landscape Supply reported its fourth-quarter 2025 results, with sales rising to US$1,045.6 million and its quarterly net loss narrowing to US$9 million, while full-year sales reached US$4,704.8 million and net income increased to US$151.8 million. The company also improved its earnings per share from continuing operations for the full year, with diluted EPS rising from US$2.71 to US$3.37, underlining higher profitability on slightly higher revenue. We’ll now examine how this...

Ichor Holdings (ICHR) just wrapped up FY 2025 with Q4 revenue of US$223.6 million and a basic EPS loss of US$0.46, while trailing twelve month figures show revenue of US$947.7 million and a basic EPS loss of US$1.54. Over recent quarters, the company has seen quarterly revenue move between US$211.1 million and US$244.5 million, with basic EPS losses ranging from US$0.08 to US$0.67. This pattern keeps the focus squarely on how efficiently each dollar of sales is translating into earnings. With...

Ciena Corporation ( NYSE:CIEN ) shares have continued their recent momentum with a 30% gain in the last month alone...

Verizon Communications Inc. ( NYSE:VZ ) will increase its dividend from last year's comparable payment on the 1st of...

The loanDepot, Inc. ( NYSE:LDI ) share price has fared very poorly over the last month, falling by a substantial 27...

Molina Healthcare, Inc. ( NYSE:MOH ) shares have had a horrible month, losing 31% after a relatively good period...

iRhythm Technologies, Inc. has voluntarily deregistered its Common Stock. The company has completed a holding company reorganization. iRhythm Holdings, Inc. now serves as the new public entity for shareholders. The changes affect the stock associated with NasdaqGS:IRTC and the prior operating company. iRhythm focuses on cardiac monitoring solutions, so any change in its corporate structure tends to attract attention from investors who follow medical technology names. The move to a holding...